Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Revenue | 5M | 11M | 11M | 10M | 10M |
| Gross Profit | 1M | 5M | 5M | 5M | 5M |
| Operating Income | -8M | -7M | -9M | -8M | -5M |
| EBITDA | -8M | -6M | -9M | -7M | -4M |
| Net Income | -1M | -6M | -9M | -8M | -3M |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$0.563
-6.17% today
1Y Change
-7.69%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Scientific Industries, Inc. (SCND) is a Technology stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.56 and down 7.7% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -52.8%, EPS growth of +82.0%, a dividend yield of 0.0%. What stands out right now is revenue -52.8%, EPS +82.0%, free cash flow -117.1% with operating margin -156.1% and ROIC -67.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SCND price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SCND
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SCND Max Drawdown
-43.75%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SCND and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$9.8M
-6.7% YoY
FY Net Income
-$3.1M
+61.8% YoY
Free Cash Flow
-$3.6M
+42.6% YoY
Revenue Growth
-52.8%
EPS Growth
+82.0%
Gross Margin
25.8%
Net Margin
-24.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Revenue | 5M | 11M | 11M | 10M | 10M |
| Gross Profit | 1M | 5M | 5M | 5M | 5M |
| Operating Income | -8M | -7M | -9M | -8M | -5M |
| EBITDA | -8M | -6M | -9M | -7M | -4M |
| Net Income | -1M | -6M | -9M | -8M | -3M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | 955K | 588K | 796K | 2M | 10M |
| Total Assets | 13M | 12M | 17M | 18M | 29M |
| Total Liabilities | 2M | 2M | 3M | 3M | 3M |
| Shareholder Equity | 11M | 9M | 14M | 15M | 26M |
| Total Debt | 967K | 1M | 1M | 0 | 1M |
| Net Debt | 12K | 414K | 536K | -2M | -8M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
+42.1% YoY
Capital Expenditures
257K
+49.1% YoY
Free Cash Flow
4M
+42.6% YoY
Key ratios
Gross Margin
25.8%
Operating Margin
-156.1%
Net Margin
-24.1%
ROE
-12.6%
Debt / Equity
0.09x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.